Skip to content

Childhood and adolescent ADHD

TL;DR — Childhood ADHD is assessed across home and school because impairment and behavior are context-dependent (Wolraich 2019, PMID 31570648). In the 579-child MTA trial, carefully managed medication and combined care outperformed intensive behavioral care and community treatment for core symptoms at 14 months; combined care added gains in selected non-core domains (MTA Cooperative Group 1999, PMID 10591283). Parent, classroom and organizational interventions target functioning that symptom medication alone may not normalize. Adolescence adds autonomy, driving, substance exposure, adherence and transition-of-care risks.

Developmental and setting-specific assessment

For ages 4–18, the AAP guideline places developmental level, impairment, multiple settings, comorbidity and family preferences inside the assessment-treatment loop (Wolraich 2019, PMID 31570648). Preschool diagnosis requires particular caution because normative activity and language development vary quickly.

Treatment by target

Target Evidence-supported approach What to measure
Core symptoms Stimulant or nonstimulant medication when indicated Parent and teacher ratings, adverse effects
Parent–child interaction Behavioral parent training Conflict, consistency, functioning
Classroom behavior Contingency/classroom management Direct school outcomes
Organization Skills and school-based supports Materials, assignments, completion
Comorbidity Integrated disorder-specific care Both ADHD and comorbid outcomes

The MTA randomized 579 children aged 7–9.9 years to medication management, intensive behavioral treatment, combined treatment or community care for 14 months. Medication management and combined care produced the largest core-symptom improvement; combined care showed advantages for some oppositional, internalizing, social, family and reading outcomes (MTA Cooperative Group 1999, PMID 10591283).

Growth, sleep and physical monitoring

Long-term methylphenidate synthesis included 18 studies and 4,868 participants; changes in height and weight z scores were statistically significant but small, with weight effects most evident in the first 12 months and height effects within 24–30 months (Carucci 2021, PMID 33080250). Monitoring is preferable to assuming either no effect or inevitable clinically important growth suppression.

Adolescence and transition

Adolescence changes medication ownership, confidentiality, driving exposure, school demands and diversion risk. Transition plans should name who will prescribe, monitor comorbidity, document accommodations and carry developmental evidence into adult services.

How to read the evidence

  • Diagnostic case–control separation is not the same as accuracy among referred patients.
  • Symptom change is not interchangeable with functional improvement.
  • Short randomized trials estimate acute efficacy, not decades-long benefit or harm.
  • Observational within-person and target-trial designs reduce some confounding but remain nonrandomized.
  • Parent, teacher, clinician, self-report and objective tasks measure different vantage points.
  • Statistical significance does not establish a patient-important effect.
  • Population averages should not be converted into deterministic individual predictions.
  • Absence of evidence in a subgroup is not evidence of identical effects.

Minimum standards for the next evidence generation

  1. Prespecify one primary outcome and its clinically important threshold.
  2. Report symptoms, function, quality of life and harms separately.
  3. Use clinically relevant comparators rather than only healthy controls.
  4. Retain and report participants who discontinue treatment.
  5. Test generalization across sex, age, ancestry, comorbidity and setting.
  6. Separate model development, internal validation and external validation.
  7. Declare medication exposure, concomitant care and rater blinding.
  8. Make null and contradictory results visible rather than averaging away design differences.

Recurring evidence gaps

  • Females, older adults and people with complex comorbidity remain underrepresented.
  • Functional outcomes are measured less consistently than core symptoms.
  • Follow-up usually ends before major educational or occupational transitions.
  • Comparator choice often makes effects look more or less specific than they are.
  • Treatment discontinuation and switching weaken long-term causal contrasts.
  • Independent replication is uncommon for biomarkers and digital interventions.

Retrieved evidence map

The following records were retrieved through this page’s six live PubMed searches. Inclusion here means the record is directly relevant to the page’s scope; it does not imply equal quality or endorsement of its conclusions.

Citation Indexed study lens Directly studied question/title Interpretation boundary
Wolraich 2019, PMID 31570648 Journal Article, Practice Guideline Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Interpret within its sampled population and comparator
MTA Cooperative Group 1999, PMID 10591283 Clinical Trial, Comparative Study A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Interpret within its sampled population and comparator
Carucci 2021, PMID 33080250 Journal Article, Meta-Analysis Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis. Interpret within its sampled population and comparator
Swanson 2008, PMID 18573923 Consensus Statement, Journal Article Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. Interpret within its sampled population and comparator
Granero 2021, PMID 34836314 Journal Article, Systematic Review The Role of Iron and Zinc in the Treatment of ADHD among Children and Adolescents: A Systematic Review of Randomized Clinical Trials. Interpret within its sampled population and comparator
Storebø 2023, PMID 36971690 Systematic Review, Journal Article Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Interpret within its sampled population and comparator
Catalá-López 2017, PMID 28700715 Journal Article, Systematic Review The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. Interpret within its sampled population and comparator
Lin 2025, PMID 40327858 Journal Article, Review Effectiveness of Serious Games as Digital Therapeutics for Enhancing the Abilities of Children With Attention-Deficit/Hyperactivity Disorder (ADHD): Systematic Literature Review. Interpret within its sampled population and comparator
Oh 2024, PMID 36862162 Meta-Analysis, Systematic Review Effects of game-based digital therapeutics on attention deficit hyperactivity disorder in children and adolescents as assessed by parents or teachers: a systematic review and meta-analysis. Interpret within its sampled population and comparator
Vijin 2026, PMID 42287019 Journal Article, Review Effectiveness of an attention enhancement task on executive function in children with attention deficit-hyperactivity disorder: A systematic review and meta-analysis. Interpret within its sampled population and comparator
Storebø 2025, PMID 41342306 Systematic Review, Journal Article Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Interpret within its sampled population and comparator
Bushe 2013, PMID 23777626 Journal Article Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a meta-analysis of atomoxetine and methylphenidate comparator clinical trials. Interpret within its sampled population and comparator
Özgen 2021, PMID 34501355 Journal Article, Review Treatment of Adolescents with Concurrent Substance Use Disorder and Attention-Deficit/Hyperactivity Disorder: A Systematic Review. Interpret within its sampled population and comparator
Carpentier 2017, PMID 28272130 Journal Article, Systematic Review Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us? Interpret within its sampled population and comparator
Santos 2021, PMID 35509804 Journal Article A review of Cochrane reviews on pharmacological treatment for attention deficit hyperactivity disorder. Interpret within its sampled population and comparator
Rajaprakash 2022, PMID 35229109 Journal Article, Review Attention-Deficit/Hyperactivity Disorder. Interpret within its sampled population and comparator
Dobrosavljevic 2023, PMID 37725058 Journal Article, Review The diagnosis and treatment of attention-deficit hyperactivity disorder (ADHD) in older adults. Interpret within its sampled population and comparator
Zhao 2024, PMID 38728075 Journal Article, Randomized Controlled Trial A Digital Cognitive-Physical Intervention for Attention-Deficit/Hyperactivity Disorder: Randomized Controlled Trial. Interpret within its sampled population and comparator
Research consortium for non-pharmacological interventions on ADHD 2024, PMID 38326137 Journal Article, Review Non-pharmacological treatment of Attention Deficit Disorder with or without Hyperactivity (ADHD). Overview and report of the first international symposium on the non-pharmacological management of ADHD. Interpret within its sampled population and comparator
Young 2020, PMID 32787804 Journal Article, Research Support, Non-U.S. Gov't Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/ hyperactivity disorder in girls and women. Interpret within its sampled population and comparator
Bölte 2025, PMID 39832687 Journal Article, Review Social cognition in autism and ADHD. Interpret within its sampled population and comparator
Cortese 2025, PMID 40948064 Journal Article Attention-deficit/hyperactivity disorder (ADHD) in adults: evidence base, uncertainties and controversies. Interpret within its sampled population and comparator
Zhu 2023, PMID 37033046 Journal Article, Research Support, Non-U.S. Gov't Comparative effectiveness of various physical exercise interventions on executive functions and related symptoms in children and adolescents with attention deficit hyperactivity disorder: A systematic review and network meta-analysis. Interpret within its sampled population and comparator
Gosling 2025, PMID 41297970 Journal Article, Systematic Review Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making. Interpret within its sampled population and comparator
Claussen 2024, PMID 35438451 Journal Article, Meta-Analysis All in the Family? A Systematic Review and Meta-analysis of Parenting and Family Environment as Risk Factors for Attention-Deficit/Hyperactivity Disorder (ADHD) in Children. Interpret within its sampled population and comparator
Dekkers 2022, PMID 34224837 Journal Article, Meta-Analysis Meta-analysis: Which Components of Parent Training Work for Children With Attention-Deficit/Hyperactivity Disorder? Interpret within its sampled population and comparator
Lee 2022, PMID 35847187 Journal Article, Review Effectiveness of mindfulness parent training on parenting stress and children's ADHD-related behaviors: A systematic review and meta-analysis. Interpret within its sampled population and comparator
Westwood 2025, PMID 39661381 Journal Article, Systematic Review Neurofeedback for Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis. Interpret within its sampled population and comparator
Rimestad 2019, PMID 27179355 Journal Article, Meta-Analysis Short- and Long-Term Effects of Parent Training for Preschool Children With or at Risk of ADHD: A Systematic Review and Meta-Analysis. Interpret within its sampled population and comparator
Cortese 2015, PMID 25721181 Journal Article, Meta-Analysis Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials. Interpret within its sampled population and comparator
Mulqueen 2015, PMID 24071773 Journal Article, Meta-Analysis Meta-analysis: parental interventions for preschool ADHD. Interpret within its sampled population and comparator
Hornstra 2023, PMID 35417075 Journal Article, Review Review: Which components of behavioral parent and teacher training work for children with ADHD? - a metaregression analysis on child behavioral outcomes. Interpret within its sampled population and comparator

Open questions

  • Which school interventions produce durable academic rather than rating-scale gains? (MTA Cooperative Group 1999, PMID 10591283)
  • Which adolescents benefit from combined care beyond well-managed medication? (Swanson 2008, PMID 18573923)
  • What monitoring strategy distinguishes transient appetite effects from meaningful growth change? (Carucci 2021, PMID 33080250)

References

  1. Wolraich et al. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2019;144. PMID 31570648
  2. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Archives of general psychiatry. 1999;56:1073-86. PMID 10591283
  3. Carucci et al. Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis. Neuroscience and biobehavioral reviews. 2021;120:509-525. PMID 33080250
  4. Swanson et al. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary. Journal of attention disorders. 2008;12:4-14. PMID 18573923
  5. Granero et al. The Role of Iron and Zinc in the Treatment of ADHD among Children and Adolescents: A Systematic Review of Randomized Clinical Trials. Nutrients. 2021;13. PMID 34836314
  6. Storebø et al. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). The Cochrane database of systematic reviews. 2023;3:CD009885. PMID 36971690
  7. Catalá-López et al. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. PloS one. 2017;12:e0180355. PMID 28700715
  8. Lin et al. Effectiveness of Serious Games as Digital Therapeutics for Enhancing the Abilities of Children With Attention-Deficit/Hyperactivity Disorder (ADHD): Systematic Literature Review. JMIR serious games. 2025;13:e60937. PMID 40327858
  9. Oh et al. Effects of game-based digital therapeutics on attention deficit hyperactivity disorder in children and adolescents as assessed by parents or teachers: a systematic review and meta-analysis. European child & adolescent psychiatry. 2024;33:481-493. PMID 36862162
  10. Vijin et al. Effectiveness of an attention enhancement task on executive function in children with attention deficit-hyperactivity disorder: A systematic review and meta-analysis. Journal of child and adolescent mental health. 2026:1-14. PMID 42287019
  11. Storebø et al. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). The Cochrane database of systematic reviews. 2025;12:CD009885. PMID 41342306
  12. Bushe et al. Suicide related events and attention deficit hyperactivity disorder treatments in children and adolescents: a meta-analysis of atomoxetine and methylphenidate comparator clinical trials. Child and adolescent psychiatry and mental health. 2013;7:19. PMID 23777626
  13. Özgen et al. Treatment of Adolescents with Concurrent Substance Use Disorder and Attention-Deficit/Hyperactivity Disorder: A Systematic Review. Journal of clinical medicine. 2021;10. PMID 34501355
  14. Carpentier et al. Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us? Harvard review of psychiatry. 2017;25:50-64. PMID 28272130
  15. Santos et al. A review of Cochrane reviews on pharmacological treatment for attention deficit hyperactivity disorder. Dementia & neuropsychologia. 2021;15:421-427. PMID 35509804
  16. Rajaprakash et al. Attention-Deficit/Hyperactivity Disorder. Pediatrics in review. 2022;43:135-147. PMID 35229109
  17. Dobrosavljevic et al. The diagnosis and treatment of attention-deficit hyperactivity disorder (ADHD) in older adults. Expert review of neurotherapeutics. 2023;23:883-893. PMID 37725058
  18. Zhao et al. A Digital Cognitive-Physical Intervention for Attention-Deficit/Hyperactivity Disorder: Randomized Controlled Trial. Journal of medical Internet research. 2024;26:e55569. PMID 38728075
  19. Research consortium for non-pharmacological interventions on ADHD, et al. Non-pharmacological treatment of Attention Deficit Disorder with or without Hyperactivity (ADHD). Overview and report of the first international symposium on the non-pharmacological management of ADHD. L'Encephale. 2024;50:309-328. PMID 38326137
  20. Young et al. Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/ hyperactivity disorder in girls and women. BMC psychiatry. 2020;20:404. PMID 32787804
  21. Bölte. Social cognition in autism and ADHD. Neuroscience and biobehavioral reviews. 2025;169:106022. PMID 39832687
  22. Cortese et al. Attention-deficit/hyperactivity disorder (ADHD) in adults: evidence base, uncertainties and controversies. World psychiatry : official journal of the World Psychiatric Association (WPA). 2025;24:347-371. PMID 40948064
  23. Zhu et al. Comparative effectiveness of various physical exercise interventions on executive functions and related symptoms in children and adolescents with attention deficit hyperactivity disorder: A systematic review and network meta-analysis. Frontiers in public health. 2023;11:1133727. PMID 37033046
  24. Gosling et al. Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making. BMJ (Clinical research ed.). 2025;391:e085875. PMID 41297970
  25. Claussen et al. All in the Family? A Systematic Review and Meta-analysis of Parenting and Family Environment as Risk Factors for Attention-Deficit/Hyperactivity Disorder (ADHD) in Children. Prevention science : the official journal of the Society for Prevention Research. 2024;25:249-271. PMID 35438451
  26. Dekkers et al. Meta-analysis: Which Components of Parent Training Work for Children With Attention-Deficit/Hyperactivity Disorder? Journal of the American Academy of Child and Adolescent Psychiatry. 2022;61:478-494. PMID 34224837
  27. Lee et al. Effectiveness of mindfulness parent training on parenting stress and children's ADHD-related behaviors: A systematic review and meta-analysis. Hong Kong journal of occupational therapy : HKJOT. 2022;35:3-24. PMID 35847187
  28. Westwood et al. Neurofeedback for Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis. JAMA psychiatry. 2025;82:118-129. PMID 39661381
  29. Rimestad et al. Short- and Long-Term Effects of Parent Training for Preschool Children With or at Risk of ADHD: A Systematic Review and Meta-Analysis. Journal of attention disorders. 2019;23:423-434. PMID 27179355
  30. Cortese et al. Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials. Journal of the American Academy of Child and Adolescent Psychiatry. 2015;54:164-74. PMID 25721181
  31. Mulqueen et al. Meta-analysis: parental interventions for preschool ADHD. Journal of attention disorders. 2015;19:118-24. PMID 24071773
  32. Hornstra et al. Review: Which components of behavioral parent and teacher training work for children with ADHD? - a metaregression analysis on child behavioral outcomes. Child and adolescent mental health. 2023;28:258-268. PMID 35417075